IMVT
Immunovant Inc Earnings
$26.08
Earnings Summary
Revenue | $0Mn |
Net Profits | $-109.12Mn |
Net Profit Margins | -Inf% |
Immunovant Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2024. On a quarterly growth basis, Immunovant Inc has generated NaN% jump in its revenue since last 3-months.
Immunovant Inc’s net profit fell -86.01% since last year same period to $-109.12Mn in the Q3 2024. On a quarterly growth basis, Immunovant Inc has generated -25.21% fall in its net profits since last 3-months.
Immunovant Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2024. On a quarterly growth basis, Immunovant Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Immunovant Inc post its latest quarter earningsEPS Estimate Current Quarter | -0.6 |
EPS Estimate Current Year | -0.6 |
Immunovant Inc’s earning per share (EPS) estimates for the current quarter stand at -0.6 - a -13.21% fall from last quarter’s estimates.
Immunovant Inc’s earning per share (EPS) estimates for the current year stand at -0.6.
Key Ratios
Key ratios of the Immunovant Inc post its Q3 2024 earningsEarning Per Share (EPS) | -0.74 |
Immunovant Inc’s earning per share (EPS) fell -64.44% since last year same period to -0.74 in the Q3 2024. This indicates that the Immunovant Inc has generated -64.44% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-11-07 | -0.6 | -0.74 | -23.33% |
2024-08-06 | -0.53 | -0.6 | -13.21% |
2024-05-29 | -0.43 | -0.52 | -20.93% |
₹0 US Stocks a/c Opening Fee